Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-Bromo-5-trifluoromethoxypyridine is a pyridine derivative with the molecular formula C6H3BrF3NO. It is characterized by the presence of a bromine atom and three trifluoromethoxy groups attached to a pyridine ring. This chemical compound is commonly used as a building block in organic synthesis and is known for its unique chemical properties, making it a valuable reagent in the pharmaceutical and agrochemical industries.

888327-36-4

Post Buying Request

888327-36-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

888327-36-4 Usage

Uses

Used in Pharmaceutical Industry:
2-Bromo-5-trifluoromethoxypyridine is used as a reagent for the production of various compounds in the pharmaceutical industry. Its unique chemical properties make it useful in the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical industry, 2-Bromo-5-trifluoromethoxypyridine is utilized as a reagent for the synthesis of crop protection products. Its versatility and unique properties enable the creation of innovative solutions for agricultural applications, enhancing crop yield and protection against pests and diseases.
Used in Organic Chemistry Research:
2-Bromo-5-trifluoromethoxypyridine holds significant importance in the field of organic chemistry and chemical research. Its unique structure and properties make it a valuable compound for exploring new reactions, mechanisms, and applications in organic synthesis, further expanding the horizons of chemical science.

Check Digit Verification of cas no

The CAS Registry Mumber 888327-36-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,8,3,2 and 7 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 888327-36:
(8*8)+(7*8)+(6*8)+(5*3)+(4*2)+(3*7)+(2*3)+(1*6)=224
224 % 10 = 4
So 888327-36-4 is a valid CAS Registry Number.

888327-36-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Bromo-5-(trifluoromethoxy)pyridine

1.2 Other means of identification

Product number -
Other names 2-BROMO-5-TRIFLUOROMETHOXYPYRIDINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:888327-36-4 SDS

888327-36-4Synthetic route

2-chloro-5-(trifluoromethoxy)pyridine
1206972-45-3

2-chloro-5-(trifluoromethoxy)pyridine

2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

Conditions
ConditionsYield
With trimethylsilyl bromide In propiononitrile for 24h; Reflux;81%
With trimethylsilyl bromide In propiononitrile at 100℃; for 72h;81%
6-bromo-pyridin-3-ol
55717-45-8

6-bromo-pyridin-3-ol

tetrachloromethane
56-23-5

tetrachloromethane

2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

Conditions
ConditionsYield
Stage #1: 6-bromo-pyridin-3-ol; tetrachloromethane With antimony pentafluoride at 150℃; for 8h;
Stage #2: With potassium hydroxide In water
2.9%
6-bromopyridin-3-ylboronic acid
223463-14-7

6-bromopyridin-3-ylboronic acid

2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dihydrogen peroxide; acetic acid / tetrahydrofuran / 0 - 20 °C
2: antimony pentafluoride / 8 h / 150 °C
View Scheme
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

trifluoroacetic anhydride
407-25-0

trifluoroacetic anhydride

2-bromo-5-(trifluoromethoxy)pyridin-1-ium-1-olate

2-bromo-5-(trifluoromethoxy)pyridin-1-ium-1-olate

Conditions
ConditionsYield
With dihydrogen peroxide In dichloromethane; water at 0℃; for 18h;100%
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

2,2-dimethyl-1-(2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1-(pyrimidin-5-yl)propan-1-ol

2,2-dimethyl-1-(2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1-(pyrimidin-5-yl)propan-1-ol

2,2-dimethyl-1-(2-methyl-4-(5-(trifluoromethoxy)pyridin-2-yl)phenyl)-1-(pyrimidin-5-yl)propan-1-ol

2,2-dimethyl-1-(2-methyl-4-(5-(trifluoromethoxy)pyridin-2-yl)phenyl)-1-(pyrimidin-5-yl)propan-1-ol

Conditions
ConditionsYield
With tetrakis(triphenylphosphine) palladium(0); potassium carbonate In water; N,N-dimethyl-formamide at 120℃; for 0.5h; Suzuki Coupling; Inert atmosphere; Microwave irradiation;93%
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

Ethyl bromodifluoroacetate
667-27-6

Ethyl bromodifluoroacetate

ethyl 2,2-difluoro-2-(5-(trifluoromethoxy)pyridin-2-yl)acetate

ethyl 2,2-difluoro-2-(5-(trifluoromethoxy)pyridin-2-yl)acetate

Conditions
ConditionsYield
With copper In dimethyl sulfoxide at 80℃;62%
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

carbon dioxide
124-38-9

carbon dioxide

5-(trifluoromethoxy)picolinic acid

5-(trifluoromethoxy)picolinic acid

Conditions
ConditionsYield
Stage #1: 2-bromo-5-(trifluoromethoxy)pyridine With n-butyllithium In hexane; toluene at -100 - -78℃;
Stage #2: carbon dioxide In hexane; toluene
Stage #3: With hydrogenchloride In water pH=4;
60%
Stage #1: 2-bromo-5-(trifluoromethoxy)pyridine With n-butyllithium In hexane; toluene at -78℃; for 2h;
Stage #2: carbon dioxide In hexane; toluene
Stage #3: With hydrogenchloride In hexane; water; toluene pH=4;
60%
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

ethyl (2E)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)acrylate
1009307-13-4

ethyl (2E)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)acrylate

(E)-ethyl 3-(5-(trifluoromethoxy)pyridin-2-yl)acrylate

(E)-ethyl 3-(5-(trifluoromethoxy)pyridin-2-yl)acrylate

Conditions
ConditionsYield
With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium carbonate In 1,2-dimethoxyethane; water at 110℃; for 0.5h; Microwave irradiation; Sealed tube; Inert atmosphere;56%
With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium carbonate In 1,2-dimethoxyethane; water at 110℃; for 0.5h; Microwave irradiation;56%
3-bromo-1H-1,2,4-triazole
7343-33-1

3-bromo-1H-1,2,4-triazole

2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

2-(3-bromo-1H-1,2,4-triazol-1-yl)-5-(trifluoromethoxy)pyridine

2-(3-bromo-1H-1,2,4-triazol-1-yl)-5-(trifluoromethoxy)pyridine

Conditions
ConditionsYield
With copper(l) iodide; caesium carbonate In N,N-dimethyl-formamide at 100℃; for 1h; Inert atmosphere; Microwave irradiation;31%
With copper(l) iodide; caesium carbonate In N,N-dimethyl-formamide at 100℃; for 1h; Sealed tube; Microwave irradiation;31%
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

methyl 5-chloro-2-hydroxybenzoate
4068-78-4

methyl 5-chloro-2-hydroxybenzoate

methyl 5-chloro-2-[[5-(trifluoromethoxy)-2-pyridyl]oxy]benzoate

methyl 5-chloro-2-[[5-(trifluoromethoxy)-2-pyridyl]oxy]benzoate

Conditions
ConditionsYield
With 2-Picolinic acid; potassium phosphate; copper(l) iodide In dimethyl sulfoxide at 80℃; for 19h; Inert atmosphere;31%
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

1-t-Butoxycarbonylpiperazine
57260-71-6

1-t-Butoxycarbonylpiperazine

tert-butyl 4-[5-(trifluoromethoxy)pyridin-2-yl]piperazine-1-carboxylate

tert-butyl 4-[5-(trifluoromethoxy)pyridin-2-yl]piperazine-1-carboxylate

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl; sodium t-butanolate In toluene at 80℃; for 16h;28%
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

C14H20N2O3

C14H20N2O3

C20H22F3N3O4

C20H22F3N3O4

Conditions
ConditionsYield
With 15-crown-5; sodium hydride In N,N-dimethyl-formamide; mineral oil at 80℃; for 16h;19%
5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)oxazole
942070-84-0

5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)oxazole

2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

5-(5-(trifluoromethoxy)pyridin-2-yl)oxazole

5-(5-(trifluoromethoxy)pyridin-2-yl)oxazole

Conditions
ConditionsYield
With bis-triphenylphosphine-palladium(II) chloride; sodium carbonate In tetrahydrofuran for 16h; Suzuki Coupling; Reflux;5.1%
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

N-(2-amino-2-methylcyclopentyl)-2-(2H-1,2,3-triazol-2-yl)benzamide hydrochloride

N-(2-amino-2-methylcyclopentyl)-2-(2H-1,2,3-triazol-2-yl)benzamide hydrochloride

N-(2-methyl-2-{[5-(trifluoromethoxy)pyridin-2-yl]amino}cyclopentyl)-2-(2H-1,2,3-triazol-2-yl)benzamide

N-(2-methyl-2-{[5-(trifluoromethoxy)pyridin-2-yl]amino}cyclopentyl)-2-(2H-1,2,3-triazol-2-yl)benzamide

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl; sodium t-butanolate In toluene at 140℃; for 17h; Inert atmosphere;
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

N-[(1S,2S)-2-aminocyclopentyl]-2-(2H-1,2,3-triazol-2-yl)benzamide hydrochloride

N-[(1S,2S)-2-aminocyclopentyl]-2-(2H-1,2,3-triazol-2-yl)benzamide hydrochloride

2-(2H-1,2,3-triazol-2-yl)-N-[(1S,2S)-2-{[5-(trifluoromethoxy)pyridin-2-yl]amino}cyclopentyl]benzamide

2-(2H-1,2,3-triazol-2-yl)-N-[(1S,2S)-2-{[5-(trifluoromethoxy)pyridin-2-yl]amino}cyclopentyl]benzamide

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl; sodium t-butanolate In toluene at 110℃; for 17h; Sealed tube; Inert atmosphere;
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

N-[(1S,2S)-2-aminocyclopentyl]-5-chloro-2-(2H-1,2,3-triazol-2-yl)benzamide hydrochloride

N-[(1S,2S)-2-aminocyclopentyl]-5-chloro-2-(2H-1,2,3-triazol-2-yl)benzamide hydrochloride

5-chloro-2-(2H-1,2,3-triazol-2-yl)-N-[(1S,2S)-2-{[5-(trifluoromethoxy)pyridin-2-yl]amino}cyclopentyl]benzamide

5-chloro-2-(2H-1,2,3-triazol-2-yl)-N-[(1S,2S)-2-{[5-(trifluoromethoxy)pyridin-2-yl]amino}cyclopentyl]benzamide

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); potassium tert-butylate; 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl In toluene at 120℃; for 0.25h; Inert atmosphere;
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

N-[(1S,2S)-2-amino-4,4-difluorocyclopentyl]-2-(2H-1,2,3-triazol-2-yl)benzamide

N-[(1S,2S)-2-amino-4,4-difluorocyclopentyl]-2-(2H-1,2,3-triazol-2-yl)benzamide

N-[(1S,2S)-4,4-difluoro-2-{[5-(trifluoromethoxy)pyridin-2-yl]amino}cyclopentyl]-2-(2H-1,2,3-triazol-2-yl)benzamide

N-[(1S,2S)-4,4-difluoro-2-{[5-(trifluoromethoxy)pyridin-2-yl]amino}cyclopentyl]-2-(2H-1,2,3-triazol-2-yl)benzamide

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl; sodium t-butanolate In toluene at 120℃; for 17h; Inert atmosphere;
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

2,2-difluoro-2-(5-(trifluoromethoxy)pyridin-2-yl)ethanol

2,2-difluoro-2-(5-(trifluoromethoxy)pyridin-2-yl)ethanol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: copper / dimethyl sulfoxide / 80 °C
2: sodium tetrahydroborate; ethanol / 0.5 h / 20 °C
View Scheme
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

2,2-difluoro-2-(5-(trifluoromethoxy)pyridin-2-yl)ethyltrifluoromethanesulfonate

2,2-difluoro-2-(5-(trifluoromethoxy)pyridin-2-yl)ethyltrifluoromethanesulfonate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: copper / dimethyl sulfoxide / 80 °C
2: sodium tetrahydroborate; ethanol / 0.5 h / 20 °C
3: N-ethyl-N,N-diisopropylamine / diethyl ether / 1 h / 0 - 20 °C / Inert atmosphere
View Scheme
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

N-(1-(2,2-difluoro-2-(5-(trifluoromethoxy)pyridin-2-yl)ethyl)piperidin-4-yl)-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

N-(1-(2,2-difluoro-2-(5-(trifluoromethoxy)pyridin-2-yl)ethyl)piperidin-4-yl)-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: copper / dimethyl sulfoxide / 80 °C
2: sodium tetrahydroborate; ethanol / 0.5 h / 20 °C
3: N-ethyl-N,N-diisopropylamine / diethyl ether / 1 h / 0 - 20 °C / Inert atmosphere
4: N-ethyl-N,N-diisopropylamine / dichloromethane; N,N-dimethyl-formamide / 60 °C
View Scheme
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

N-(1-(2,2-difluoro-2-(5-(trifluoromethoxy)pyridin-2-yl)ethyl)piperidin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine

N-(1-(2,2-difluoro-2-(5-(trifluoromethoxy)pyridin-2-yl)ethyl)piperidin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: copper / dimethyl sulfoxide / 80 °C
2: sodium tetrahydroborate; ethanol / 0.5 h / 20 °C
3: N-ethyl-N,N-diisopropylamine / diethyl ether / 1 h / 0 - 20 °C / Inert atmosphere
4: N-ethyl-N,N-diisopropylamine / dichloromethane; N,N-dimethyl-formamide / 60 °C
5: sodium hydroxide / water; tetrahydrofuran / 3 h / 60 °C
View Scheme
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

N-(1-(2,2-difluoro-2-(5-(trifluoromethoxy)pyridin-2-yl)ethyl)piperidin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride

N-(1-(2,2-difluoro-2-(5-(trifluoromethoxy)pyridin-2-yl)ethyl)piperidin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: copper / dimethyl sulfoxide / 80 °C
2: sodium tetrahydroborate; ethanol / 0.5 h / 20 °C
3: N-ethyl-N,N-diisopropylamine / diethyl ether / 1 h / 0 - 20 °C / Inert atmosphere
4: N-ethyl-N,N-diisopropylamine / dichloromethane; N,N-dimethyl-formamide / 60 °C
5: sodium hydroxide / water; tetrahydrofuran / 3 h / 60 °C
6: hydrogenchloride / methanol / 0.5 h / 20 °C
View Scheme
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

N-[2-(1-benzylpiperidin-4-yl)ethyl]piperidine-4-carboxamide

N-[2-(1-benzylpiperidin-4-yl)ethyl]piperidine-4-carboxamide

N-[2-(1-benzylpiperidin-4-yl)ethyl]-1-[5-(trifluoromethoxy)pyridin-2-yl]piperidine-4-carboxamide

N-[2-(1-benzylpiperidin-4-yl)ethyl]-1-[5-(trifluoromethoxy)pyridin-2-yl]piperidine-4-carboxamide

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl; sodium t-butanolate In toluene at 100℃;
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

6-bromo-(3-trifluoromethoxy)pyridine-2-carbonitrile

6-bromo-(3-trifluoromethoxy)pyridine-2-carbonitrile

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dihydrogen peroxide / dichloromethane; water / 18 h / 0 °C
2: triethylamine / acetonitrile / 40 h / 80 °C
View Scheme
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

1-[5-(trifluoromethoxy)pyridin-2-yl]piperazine

1-[5-(trifluoromethoxy)pyridin-2-yl]piperazine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium t-butanolate; 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl; tris-(dibenzylideneacetone)dipalladium(0) / toluene / 16 h / 80 °C
2: hydrogenchloride / water; 1,4-dioxane / 4 h / 20 °C
View Scheme
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

N-[5-[(tert-butyldimethylsilyl)oxy]pyridin-2-yl]-4-[5-(trifluoromethoxy)pyridin-2-yl]piperazine-1-carboxamide

N-[5-[(tert-butyldimethylsilyl)oxy]pyridin-2-yl]-4-[5-(trifluoromethoxy)pyridin-2-yl]piperazine-1-carboxamide

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium t-butanolate; 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl; tris-(dibenzylideneacetone)dipalladium(0) / toluene / 16 h / 80 °C
2: hydrogenchloride / water; 1,4-dioxane / 4 h / 20 °C
3: triethylamine / dichloromethane / 16 h / 20 °C
View Scheme
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

N-(5-hydroxypyridin-2-yl)-4-[5-(trifluoromethoxy)pyridin-2-yl]piperazine-1-carboxamide

N-(5-hydroxypyridin-2-yl)-4-[5-(trifluoromethoxy)pyridin-2-yl]piperazine-1-carboxamide

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: sodium t-butanolate; 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl; tris-(dibenzylideneacetone)dipalladium(0) / toluene / 16 h / 80 °C
2: hydrogenchloride / water; 1,4-dioxane / 4 h / 20 °C
3: triethylamine / dichloromethane / 16 h / 20 °C
4: hydrogenchloride / water; tetrahydrofuran / 2 h / 20 °C
View Scheme
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

5-(trifluoromethoxy)-2-(3-vinyl-1H-1,2,4-triazol-1-yl)pyridine

5-(trifluoromethoxy)-2-(3-vinyl-1H-1,2,4-triazol-1-yl)pyridine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: caesium carbonate; copper(l) iodide / N,N-dimethyl-formamide / 1 h / 100 °C / Sealed tube; Microwave irradiation
2: potassium carbonate; tetrakis(triphenylphosphine) palladium(0) / N,N-dimethyl-formamide; water / 0.5 h / 90 °C / Sealed tube; Microwave irradiation
View Scheme
2-bromo-5-(trifluoromethoxy)pyridine
888327-36-4

2-bromo-5-(trifluoromethoxy)pyridine

4,4-difluoroazepane
1094073-72-9

4,4-difluoroazepane

4,4-difluoro-1-(5-(trifluoromethoxy)pyridin-2-yl)azepane

4,4-difluoro-1-(5-(trifluoromethoxy)pyridin-2-yl)azepane

Conditions
ConditionsYield
With [(2-di-cyclohexylphosphino-3,6-dimethoxy-2’,4’,6’-triisopropyl-1,1‘-biphenyl)-2-(2‘-amino-1,1’-biphenyl)]palladium(II) methanesulfonate; sodium t-butanolate In tetrahydrofuran at 60℃; for 12h; Inert atmosphere;
With [(2-di-cyclohexylphosphino-3,6-dimethoxy-2’,4’,6’-triisopropyl-1,1‘-biphenyl)-2-(2‘-amino-1,1’-biphenyl)]palladium(II) methanesulfonate; sodium t-butanolate In tetrahydrofuran at 25 - 60℃; for 12h; Inert atmosphere;

888327-36-4Downstream Products

888327-36-4Relevant articles and documents

Preparation method of 2-bromo-5-(trifluoromethoxy)pyridine

-

Paragraph 0061; 0073-0076; 0088-0090, (2022/01/12)

The invention discloses a preparation method of 2-bromine-5-(trifluoromethoxy)pyridine, which comprises the following steps: reacting 2-bromo-5-hydroxypyridine (compound 1) with ethyl difluorobromoacetate (compound 1A) in the presence of organic alkali to generate a compound 2; carrying out ester group hydrolysis reaction on the compound 2 in the presence of an alkaline reagent to generate a compound 3; carrying out acylating chlorination on carboxyl of the compound 3 and oxalyl chloride under the catalysis of N,N-dimethylformamide, concentrating reaction liquid, and dropwise adding the concentrated reaction liquid and 2,2'-azodiisobutyronitrile (AIBN) into a bromotrichloromethane solution of 2-mercaptopyridine nitrogen oxide sodium salt (compound 3A) to obtain a compound 4; and dropwise adding a silver tetrafluoroborate solution into the solution of the compound 4, and conducting reacting to generate the final product 2-bromo-5-(trifluoromethoxy)pyridine. The method has the advantages of environment-friendly and easily available raw materials, mild conditions, easiness in operation, suitability for kilogram-level production and the like.

Iminothiadiazine Dioxide Compounds as BACE Inhibitors, Compositions and Their Use

-

Paragraph 0631, (2015/11/16)

In its many embodiments, the present invention provides certain iminothiadiazine dioxide compounds, including compounds Formula (I): and include stereoisomers thereof, and pharmaceutically acceptable salts of said compounds stereoisomers, wherein each of R1, R2, R3, R4, R5, R9, ring A, ring B, m, n, p, -L1-, -L2-, and -L3- is selected independently and as defined herein. The novel iminothiadiazine dioxide compounds of the invention have surprisingly been found to exhibit properties which are expected to render them advantageous as BACE inhibitors and/or for the treatment and prevention of various pathologies related to β-amyloid (“Aβ”) production. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use in treating pathologies associated with amyloid beta (Aβ) protein, including Alzheimer's disease, are also disclosed.

METHOD FOR THE PREPARATION OF FUNCTIONALIZED TRIHALOMETHOXY SUBSTITUTED PYRIDINES

-

Page/Page column 38-39, (2010/04/28)

The present invention pertains to a process for the preparation of functionalized trihalomethoxypyridines of formula (I) comprising reacting hydroxypyridines with thiophosgene in the presence of a base; reacting the obtained chlorothionoformiates with elemental chlorine and finally converting trichloromethoxy pyridines to trihalomethoxy pyridines using a fluoride source.

A general approach to (trifluoromethoxy)pyridines: First X-ray structure determinations and quantum chemistry studies

Manteau, Baptiste,Genix, Pierre,Brelot, Lydia,Vors, Jean-Pierre,Pazenok, Sergiy,Giornal, Florence,Leuenberger, Charlotte,Leroux, Frederic R.

experimental part, p. 6043 - 6066 (2011/02/26)

The previously unknown 2-, 3-, and 4-(trifluoromethoxy)pyridines have now become readily accessible by means of an efficient and straightforward large-scale synthesis. Their regioselective functionalization by organometallic methods has been studied and has afforded new and highly important building blocks for life-sciences-oriented research. In addition, the first X-ray crystallographic structure determinations of (trifluoromethoxy)pyridines have been performed. Lowest-energy conformations of (trifluoromethoxy)pyridines and (trifluoromethoxy)pyridinium cations were determined by in silico studies. A general and efficient route to (trifluoromethoxy)pyridines is reported. Regioselective functionalization by organometallic methods afforded new and highly important building blocks for life-sciences-oriented research. The first X-ray crystallographic structure determinations of (trifluoromethoxy)pyridines have been performed and supported by in silico studies.

SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS MODULATORS OF PPAR

-

, (2015/10/07)

Compounds as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 888327-36-4